Back to search

Japan· JP-2699714M2025

デルゴシチニブ

A delgocitinib product containing デルゴシチニブ, registered in Japan by 塩野義製薬, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

On Japan’s NHI price listATC D11AH11

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedデルゴシチニブATCD11AH11REGISTER NO.JP-2699714M2025PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Delgocitinib is registered in 15 of 19 countries.

Countries holding a registration under ATC D11AH11 (delgocitinib), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 10 of them publish a price we can compare per daily dose

Delgocitinib · ATC D11AH11

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
デルゴシチニブ
Manufacturer
塩野義製薬
Country
Japan (JP)
ATC code
D11AH11
ATC class
Delgocitinib
Defined daily dose
40 mg, T
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fcb2dc30-4f39-4d9a-ba30-9e421de5673e
GET /v1/drugs/fcb2dc30-4f39-4d9a-ba30-9e421de5673e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "0.25%1g",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2699714M2025",
  "category": "外用薬",
  "price_yen": 135.8,
  "generic_name": "デルゴシチニブ",
  "product_name_jp": null,
  "therapeutic_class": "2699",
  "transitional_expiry": null
}

See everything about delgocitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.